What is SLE Phase III Lupuzor?
Category: Others
The SLE Phase III Lupuzor trial is a randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of a 200-mcg dose of IPP-201101 plus standard of care in patients with Systemic Lupus Erythematosus. NCT02504645
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Fear of the rectum or rectal disease (rectophobia) | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Why patients stopped taking SLE Phase III Lupuzor
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 1 |
Duration
Stopped using SLE Phase III Lupuzor
| Duration | Patients | Percentage |
|---|---|---|
| 6 months - 1 year | 1 |
Last updated: